从研究到实践：心血管护理的未来。
From Research to Practice: The Future of Cardiovascular Care.
作者信息
Manoria Prabhash C
机构信息
Cardiology, Director of Manoria Heart and Critical Care Hospital, Bhopal, IND.
出版信息
Cureus. 2025 May 20;17(5):e84473. doi: 10.7759/cureus.84473. eCollection 2025 May.
Abstract
Cardiovascular diseases (CVDs) remain the leading cause of mortality worldwide, necessitating continuous advancements in research and clinical practice. Research advancements have significantly transformed our understanding and management of CVDs. Recent breakthroughs in genomics, artificial intelligence (AI), wearable technology, and regenerative medicine are reshaping cardiovascular (CV) care. This review explores key innovations that bridge the gap between research and clinical application, emphasizing precision medicine, early detection, and personalized therapies. We also discuss challenges in implementation and future directions for optimizing CV outcomes.
摘要
心血管疾病（CVDs）仍然是全球范围内主要的死亡原因，这使得研究和临床实践需要不断取得进展。研究进展显著改变了我们对心血管疾病的理解和管理方式。基因组学、人工智能（AI）、可穿戴技术和再生医学方面的最新突破正在重塑心血管（CV）护理。本综述探讨了弥合研究与临床应用之间差距的关键创新，强调精准医学、早期检测和个性化治疗。我们还讨论了实施过程中面临的挑战以及优化心血管疾病治疗效果的未来方向。
相似文献
1
From Research to Practice: The Future of Cardiovascular Care.从研究到实践：心血管护理的未来。
Cureus. 2025 May 20;17(5):e84473. doi: 10.7759/cureus.84473. eCollection 2025 May.
2
The impact of artificial intelligence on the endoscopic assessment of inflammatory bowel disease-related neoplasia.人工智能对炎症性肠病相关肿瘤内镜评估的影响。
Therap Adv Gastroenterol. 2025 Jun 23;18:17562848251348574. doi: 10.1177/17562848251348574. eCollection 2025.
3
Dipeptidyl peptidase-4 inhibitors, glucagon-like peptide 1 receptor agonists and sodium-glucose co-transporter-2 inhibitors for people with cardiovascular disease: a network meta-analysis.二肽基肽酶-4 抑制剂、胰高血糖素样肽 1 受体激动剂和钠-葡萄糖共转运蛋白 2 抑制剂用于心血管疾病患者：一项网状荟萃分析。
Cochrane Database Syst Rev. 2021 Oct 25;10(10):CD013650. doi: 10.1002/14651858.CD013650.pub2.
4
Advancements in AI for Computational Biology and Bioinformatics: A Comprehensive Review.用于计算生物学和生物信息学的人工智能进展：全面综述。
Methods Mol Biol. 2025;2952:87-105. doi: 10.1007/978-1-0716-4690-8_6.
5
The Use of AI for Phenotype-Genotype Mapping.人工智能在表型-基因型映射中的应用。
Methods Mol Biol. 2025;2952:369-410. doi: 10.1007/978-1-0716-4690-8_21.
6
Effects of a gluten-reduced or gluten-free diet for the primary prevention of cardiovascular disease.减少或无麸质饮食对心血管疾病一级预防的影响。
Cochrane Database Syst Rev. 2022 Feb 24;2(2):CD013556. doi: 10.1002/14651858.CD013556.pub2.
7
Antidepressants for pain management in adults with chronic pain: a network meta-analysis.抗抑郁药治疗成人慢性疼痛的疼痛管理：一项网络荟萃分析。
Health Technol Assess. 2024 Oct;28(62):1-155. doi: 10.3310/MKRT2948.
8
AI-Driven Antimicrobial Peptide Discovery: Mining and Generation.人工智能驱动的抗菌肽发现：挖掘与生成
Acc Chem Res. 2025 Jun 17;58(12):1831-1846. doi: 10.1021/acs.accounts.0c00594. Epub 2025 Jun 3.
9
Comprehensive Global Analysis of Future Trends in Artificial Intelligence-Assisted Veterinary Medicine.人工智能辅助兽医学未来趋势的全球综合分析
Vet Med Sci. 2025 May;11(3):e70258. doi: 10.1002/vms3.70258.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病：网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
本文引用的文献
1
Combating cardiovascular disease disparities: The potential role of artificial intelligence.对抗心血管疾病差异：人工智能的潜在作用。
Am J Prev Cardiol. 2025 Mar 9;22:100954. doi: 10.1016/j.ajpc.2025.100954. eCollection 2025 Jun.
2
Advancements in Artificial Intelligence in Noninvasive Cardiac Imaging: A Comprehensive Review.非侵入性心脏成像中人工智能的进展：全面综述
Clin Cardiol. 2025 Jan;48(1):e70087. doi: 10.1002/clc.70087.
3
Transforming Cardiovascular Risk Prediction: A Review of Machine Learning and Artificial Intelligence Innovations.转变心血管疾病风险预测：机器学习与人工智能创新综述
Life (Basel). 2025 Jan 14;15(1):94. doi: 10.3390/life15010094.
4
Health Disparities: The Emerging Trends and Pressing Challenges.健康差距：新趋势与紧迫挑战
Eur J Investig Health Psychol Educ. 2025 Jan 8;15(1):7. doi: 10.3390/ejihpe15010007.
5
CRISPR-Cas9 in Cardiovascular Medicine: Unlocking New Potential for Treatment.CRISPR-Cas9在心血管医学中的应用：开启治疗新潜力
Cells. 2025 Jan 17;14(2):131. doi: 10.3390/cells14020131.
6
Machine learning based prediction models for cardiovascular disease risk using electronic health records data: systematic review and meta-analysis.基于机器学习利用电子健康记录数据预测心血管疾病风险的模型：系统评价与荟萃分析
Eur Heart J Digit Health. 2024 Oct 27;6(1):7-22. doi: 10.1093/ehjdh/ztae080. eCollection 2025 Jan.
7
Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors as Adjunct Therapy to Statins: A New Frontier in Cardiovascular Risk Reduction.前蛋白转化酶枯草溶菌素/克新9型（PCSK9）抑制剂作为他汀类药物的辅助治疗：降低心血管风险的新领域。
Cureus. 2024 Oct 13;16(10):e71365. doi: 10.7759/cureus.71365. eCollection 2024 Oct.
8
Mesenchymal stromal cell therapy (REGENACIP), a promising treatment option in chronic limb threatening ischemia - a narrative review.间质基质细胞治疗（REGENACIP），一种慢性肢体威胁性缺血的有前途的治疗选择-叙述性综述。
Stem Cell Res Ther. 2024 Oct 8;15(1):352. doi: 10.1186/s13287-024-03957-0.
9
Gene Therapy for Cardiovascular Disease: Clinical Perspectives.心血管疾病的基因治疗：临床视角。
Yonsei Med J. 2024 Oct;65(10):557-571. doi: 10.3349/ymj.2024.0127.
10
Advancements and challenges in stem cell transplantation for regenerative medicine.用于再生医学的干细胞移植的进展与挑战。
Heliyon. 2024 Aug 10;10(16):e35836. doi: 10.1016/j.heliyon.2024.e35836. eCollection 2024 Aug 30.
Zotero 插件